Stockholders' Equity | NOTE 7 – STOCKHOLDERS’ EQUITY Share Repurchase Program In November 2015 , the Company’s board of directors authorized a share repurchase program for common stock up to $100 millio n, which was increased in November 2016 to $125 million. In the first quarter of 2017, the Company completed the repurchase of all shares authorized under the program. In October 2017, the Company’s board of directors authorized a new share repurchase program for common stock of up to $100 million. The program is scheduled to expire December 31, 2018 . The shares may be repurchased at management’s discretion in the open market. Depending on market conditions and other factors, these repurchases may be commenced or suspended from time to time without prior notice. There were 90,528,319 shares of common stock outstanding as of March 31, 2018 . Summary of share repurchase activity under the repurchase program s : Three Months Ended March 31, March 31, 2018 2017 Number of shares acquired on the open market 1,726,825 859,830 Average price per share $ 17.39 $ 20.54 Total cost of acquired shares (in millions) $ 30 $ 18 Subsequent to quarter end, we purchased an additional 1,144,379 shares for $20 million completing the repurchase of all shares authorized under the October 2017 program. In total, under both programs, we have acquired 14,622,930 shares at an average price per share of $15. 38 fo r a total cost of $225 million. As of April 27, 2018, we had 89,682,844 shares of common stock outstanding. Equity Compensation Plans Our 2011 Omnibus Incentive Plan originally had 3 ,250,000 shares reserved for issuance under the plan. In April 2015, our shareholders approved an additional 4,250,000 shares for reservation for issuance under the plan. The plan permits the issuance of stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units and other stock-based and cash-based awards. Since the adoption of the 2011 Omnibus Incentive Plan, the Company’s Board of Directors has periodically granted stock options , restricted stock awards, restricted stock units and performance share units to directors and employees. Options and stock appreciation rights may not be granted at prices less than the fair market value of our common stock on the date of the grant, nor for a term exceeding ten years. For employees, vesting generally occurs over a three to five year period on the anniversaries of the date specified in the employees’ respective stock option, restricted stock award, restricted stock unit and performance share unit award agreement s , subject to accelerated vesting under certain circumstances set forth in the agreements. Vesting for directors generally occurs on the on e -y ear anniversary of the grant date . In the quarter ended March 31, 2018 , 222,435 pe rformance share unit awards and 502,582 shares of restricted stock units have been granted to employees and members of our board of directors. To date , since the plan’s inception in 2011, before consideration of forfeitures , 6,595,947 shares have been granted to management, members of our board of directors and key employees under this plan. A Black-Scholes option-pricing model is used to estimate the fair value of the stock options. A Monte Carlo simulation is completed to estimate the fair value of performance share unit awards with a stock price performance component. We expense the fair value of all equity grants , including performance share unit awards, on a straight-line basis over the vesting period. Accumulated Other Comprehensive Loss Accumulated other comprehensive loss in the accompanying consolidated balance sheets consists of the following (in millions): March 31, December 31, 2018 2017 Currency translation adjustments $ (210) $ (209) Pension related adjustments (1) (1) Hedge accounting adjustments (1) - Accumulated other comprehensive loss $ (212) $ (210) Earnings per Share Earnings per share are calculated in the table below (in millions , except per share amounts). Three Months Ended March 31, March 31, 2018 2017 Net income $ 18 $ 6 Less: Dividends on Series A Preferred Stock 6 6 Net income attributable to common stockholders $ 12 $ - Weighted average basic shares outstanding 91.4 94.8 Effect of dilutive securities 1.1 - Weighted average diluted shares outstanding 92.5 94.8 Net income per share: Basic $ 0.13 $ - Diluted $ 0.13 $ - Equity awards and shares of Preferred Stock are disregarded in the calculation of diluted earnings per share if they are determined to be anti-dilutive. For the three months ended March 31, 2018 and 2017 , all of the shares of the Preferred Stock were anti-dilutive. For the three months ended March 31, 2018 and 2017 , we had approximately 3.4 million and 2 .1 million anti-dilutive stock options , respectively . There were no anti-dilutive restricted stock, restricted units or performance stock unit awards for the three months ended March 31, 2018 . There were 1. 4 million anti-dilutive restricted stock, restricted units or performance stock unit awards for the three months ended March 31, 2017 . |